InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
2
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-47.9%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by ZDRAVESKI ZORAN, Director. Insider active across 1 company, notably TScan Therapeutics, Inc.. Cumulatively, 3 disclosures have been logged. Breakdown: 2 buys · 0 sell. Total volume traded: €60k. Activity tracked since 23 September 2021. The latest transaction was filed on 23 August 2024 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations3 total
54,895 shares@ US$4.8579.9% of flowVoting Common StockSEC:0000950170-24-101161:0
4,716 shares@ US$7.47570.046% mcap50.0% of flowVoting Common StockSEC:0000899243-21-037802:0
Ideal exit: 20 Jun 2022 (T+270)
4,716 shares@ US$7.475710.0% of flowVoting Common StockSEC:0000899243-21-037802
Ideal exit: 20 Jun 2022 (T+270)
3 of 3 declarations
About ZDRAVESKI ZORAN
Guy M. Arnold is a Board Member at StoneCastle Financial Corp. He brings expertise in financial strategy to the board. His role involves overseeing strategic decisions and ensuring that the company adheres to governance standards and investor expectations.
